PROGRAM
Tuesday 19 November |
|||
| 01:00 pm | Registration desk open; coffee, tea |
||
| 01:45 pm | Welcome & Introduction Symposium |
||
| Dr Maarten van Dongen, AMR Insights, The Netherlands |
|||
| 02:00 pm | Antimicrobial resistance (AMR): the global perspective |
||
| Prof. Jan Verhoef; World Health Forum, The Netherlands |
|||
| 02:30 pm | The Global AMR R&D Hub: dynamic dashboard and ambitions |
||
| Dr Jennie Hood; Global AMR R&D Hub, Berlin, Germany |
|||
| 03:00 pm | Synergizing global R&D Antimicrobials Databases: interactive plenary session |
||
| Dr Sarah Paulin; WHO, Dr Jennie Hood; Global AMR R&D Hub, Dr Shawon Lahiri; JPIAMR Dr James Kirkham; AMR Centre, Dr Maarten van Dongen; AMR Insights, others TBC |
|||
| 03:45 pm |
Coffee – tea / Infomarket |
||
| 04:00 pm | R&D antimicrobial Lugdunomycine: strategy to success and further development |
||
| Prof.dr. Gilles van Wezel; Leiden University, The Netherlands | |||
| 04:30 pm | Impact of novel molecular diagnostics on AMR |
||
| Prof. dr. Paul Savelkoul; Maastricht University Medical Center, The Netherlands |
|||
| 05:00 pm |
Network Reception (5-6 pm; with short intro on KIT) |
||
Symposium Dinner Raadszaal (NB dinner is fully booked; waiting list applies. We apologize for any inconvenience) |
|||
| 07:00 pm | Drinks and networking | ||
| 07:30 pm | Symposium Dinner: Antipasti – Main course – Dessert – Drinks included | ||
| >> Festive launch WHO Educational app on AMR | |||
| >> Presentation Global AMR Insights Ambassasor Program | |||
| 09:00 pm | Coffee – Tea – Networking | ||
| 09:30 pm | End of program | ||
Wednesday 20 November |
|||
| 08:00 am | Information desk open; coffee, tea |
||
| 08:45 am |
Introduction Parallel Program |
||
Matchmaking Sessions |
Buzz Sessions |
||
| 09:00 am | Round 1 (15′) | 09:00 am | Revitalizing neglected antimicrobial compounds |
| 09:20 am | Round 2 (15′) | Prof. Jan Verhoef; World Health Forum (NL) | |
| 09:40 am | Round 3 (15′) | 09:40 am | Companion Diagnostics contra AMR? |
| 10:00 am | Round 4 (15′) | Prof. Till Bachmann; Edinburgh Medical School (UK) | |
| 10:20 am | Round 5 (15′) | 10:20 am | Towards a global Data Technologies / AMR Hub |
| 10:40 am | Round 6 (15′) | Dr. Patrice Allibert; Allibert MDx Consulting (CAN) | |
| 11:00 am |
Coffee – Infomarket |
||
| 11:30 am | Azole resistant Aspergillus: a forgotten global threat | ||
| Prof.dr. Paul Verweij; Radboud UMC, Nijmegen, The Netherlands | |||
| 12:00 am | Integrative Medicine: the key to Antimicrobial resistance in primary care? | ||
| Dr. Esther van der Werf; Louis Bolk Institute (NL) / University of Bristol (UK) |
|||
| 12:30 am | Alternative antimicrobials: live biotherapeutics for lung infections |
||
| Ms Jeanette Mucha; Scibac Inc, (CA) USA | |||
| 01:00 pm |
Lunch – Infomarket |
||
Parallel Program (time slots reserved for Academia, Start-ups & SMEs) |
|||
Technology updates
|
Product updates
|
||
| 02:00 pm | Technology update 1 | 02:00 pm |
Novel Small-Molecule Inhibitors of Bacterial Lipoprotein Transport against Enterobacteriaceae |
| Afaf El-adl; Kyoto University (JP) | Dr Elena Breidenstein; Summit Therapeutics (UK) | ||
| 02:20 pm | Technology update 2 | 02:20 pm | Product update 2 |
| Dr Mauricio Agudelo; Bialtec (Colombia; SA) | Dr Daniel Hynes; Destiny Pharma (UK) | ||
| 02:40 pm | Technology update 3 | 02:40 pm | Product update 3 |
| Dr Gerold de Valk; BiosparQ (NL) | Dr Seweryn Bajer-Borstyn; Scope Fluidics (PL) | ||
| 03:00 pm | Technology update 4 | 03:00 pm | Product update 4 |
| Dr Janne Koskinen; ArcDia International (FI) | Dr Beatrix Foerster; Holiko (NL) | ||
| 03:20 pm | Technology update 5 | 03:20 pm | The links between antibiotic and disinfectant resistant bacteria |
| Dr James Kirkham; AMR Centre (UK) | Dr Andrew Kemp; BICS (UK) | ||
| 03:40 pm | Technology update 6 | 03:40 pm | Product update 6 |
|
Prof. Nathaniel Martin; Leiden University (NL) |
Dr Patrice Allibert; Allibert MDx Consulting (CAN) | ||
|
04:00 pm |
Tea – Infomarket |
||
| 04:30 pm | Forum discussion ‘Driving innovation to combat AMR’ |
||
| Forum members (others TBC): Kitty van Weezenbeek MD, PhD, MPH; Executive Director KNCV Tuberculosis Foundation (NL) Caroline van Oene MD; Associate Director Hospital Acute Care and Immunology MSD (NL) Prof Till Bachmann; Deputy Head of Infection Medicine & Personal Chair of Molecular Diagnostics and Infection, Edinburgh Medical School (UK) Roy Montijn PhD; Director Microbiology and Systems Biology, TNO (NL) |
|||
| 05:15 pm |
Closing remarks |
||
| 05:30 pm |
End of Symposium |
||